CClinicalTrials.gg
CompletedNCT04262726REMOTIONUpdated Jan 10, 2023

REMOTION: a Trial to Investigate the Feasibility and Potential Effectiveness of a Blended, Transdiagnostic Intervention for Symptom Reduction and Improvement of Emotion Regulation in an Outpatient Psychotherapeutic Setting

An interventional study of REMOTION and TAU in Mental Disorders, sponsored by University of Bern. Completed at 1 site in Switzerland. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2023-01-10.

Sponsored by University of Bern · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
All
01

Study summary

Emotion regulation has been identified as an important transdiagnostic factor in the treatment of mental health disorders. This study aims to examine, for the first time, REMOTION, a novel blended therapy intervention aimed at reducing symptom severity and improving emotion regulation of patients in an outpatient psychotherapy setting. REMOTION is an internet based intervention that is administered as an add-on to psychotherapy. This study aims to investigate feasibility and also potential effectiveness of REMOTION in an outpatient setting. Participants will be randomly assigned to the study conditions. Outcomes are assessed at baseline, after six weeks and after twelve weeks.

02

Conditions studied

  • Mental Disorders

Browse trials for

Keywords

  • Transdiagnostic
  • Blended therapy
  • Internet-based
  • Emotion regulation
03

In context

Mental Disorders

2,107 studies on the registry are indexed under Mental Disorders; 416 are open to participants now.

This study's enrollment of 70 is below the median of 94 across 1,574 interventional studies indexed under Mental Disorders.

Browse Mental Disorders studies →

Lead sponsor

University of Bern is the lead sponsor of 207 studies on the registry; 47 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • 18 years or older
  • In psychotherapeutic treatment at the outpatient clinic of the Department of Clinical Psychology at the University of Bern
  • Mental disorder present
  • Internet access available
  • Written informed consent

Exclusion criteria

Exclusion Criteria:

  • Current participation in another intervention, outside of the treatment at the outpatient clinic, that is geared specifically at emotion regulation
  • Current or history of psychotic disorders or bipolar disorder
  • Acute suicidality
  • Insufficient mastery of German language
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
70 participants (actual)

Study arms

  • Experimental
    REMOTION + TAU

    Participants in the REMOTION group receive REMOTION in addition to psychotherapy at the outpatient clinic of the Department of Clinical Psychology and Psychotherapy at the University of Bern.

    Behavioral: REMOTION · Behavioral: TAU

  • Active comparator
    TAU

    Participants in TAU receive psychotherapy at the outpatient clinic of the Department of Clinical Psychology and Psychotherapy at the University of Bern.

    Behavioral: TAU

Interventions

  • BehavioralREMOTION

    REMOTION is an internet-based intervention aimed at transdiagnostically reducing symptom severity and improving emotion regulation of psychotherapy patients. The structure of REMOTION is based on the idea of an extended process model of emotion regulation as postulated by J.J. Gross (2015). The program includes the following modules: introduction, psychoeducation, identification, selection, implementation and monitoring/modification. A variety of elements based on different psychotherapy approaches (Cognitive Behavioral Therapy, Emotion Focused Therapy, Dialectical Behavior Therapy etc.) are integrated in the program. Participants should work through one module per week. REMOTION is administered as an add-on to treatment as usual (TAU), which is psychotherapy at the outpatient clinic of the Department of Clinical Psychology and Psychotherapy at the University of Bern.

  • BehavioralTAU

    Treatment as usual (TAU) refers to psychotherapy at the outpatient clinic of the Department of Clinical Psychology and Psychotherapy at the University of Bern. Psychotherapy at the outpatient clinic is based on Psychological Therapy (Grawe, 1998) principles, which are largely rooted in academic psychology and which mainly draw on interventions from Cognitive Behavior Therapy. Individual case conceptualization are key in Psychological Therapy, along with general therapeutic factors and a focus on the therapeutic relationship.

06

What researchers measure

Primary outcomes

  1. General symptom severity

    Assessed with Brief Symptom Inventory (Franke, 2000, German version)

    Time frame: baseline

  2. General symptom severity

    Assessed with Brief Symptom Inventory (Franke, 2000, German version)

    Time frame: 6 weeks

  3. General symptom severity

    Assessed with Brief Symptom Inventory (Franke, 2000, German version)

    Time frame: 12 weeks

Secondary outcomes

  1. Difficulties in emotion regulation

    Assessed with Difficulties in Emotion Regulation Scale (DERS, Gratz \& Roemer, 2004, German version by Ehring et al., 2008).

    Time frame: baseline, 6 weeks,12 weeks

  2. Emotion competencies questionnaire

    Assessed with Emotion Competencies Questionnaire (SEK-27, Berking \& Znoj, 2008)

    Time frame: baseline, 6 weeks, 12 weeks

  3. Depressive Symptoms

    Assessed with Patient Health Questionnaire-9 (PHQ-9, German version by Löwe \& Spitzer, 2002).

    Time frame: baseline, 6 weeks, 12 weeks

  4. Anxiety symptoms

    Assessed with Generalized Anxiety Disorder Scale-7 (GAD-7, German version by Löwe et al., 2008)

    Time frame: baseline, 6 weeks, 12 weeks

  5. Well-Being

    Assessed with the World Health Organisation-Five Well-Being Index (German version, Brähler, et al., 2007).

    Time frame: baseline, 6 weeks, 12 weeks

  6. Health related quality of life

    Assessed with the Short Form Health Survey (SF-12, German version by Gandek et al., 1998)

    Time frame: baseline, 6 weeks, 12 weeks

  7. Feasibility parameter: number of participants taking part in the study

    Time frame: at randomization

  8. Feasibility parameter: adherence

    Adherence assessed by amount of modules completed

    Time frame: 6 weeks,12 weeks (REMOTION group only)

  9. Feasibility parameter: adherence

    Adherence assessed by amount of pages visited in REMOTION

    Time frame: 6 weeks,12 weeks (REMOTION group only)

  10. Feasibility parameter: adherence

    Adherence assessed by amount of exercises completed in REMOTION

    Time frame: 6 weeks, 12 weeks (REMOTION group only)

  11. Feasibility parameter: program usability

    Assessed with the System Usability Scale (SUS, Brooke, 1996)

    Time frame: 6 weeks, 12 weeks (REMOTION group only)

  12. Feasibility parameter: user experience

    Assessed with the meCUE questionnaire (Minge \& Riedel, 2013)

    Time frame: 6 weeks, 12 weeks (REMOTION group only)

  13. Feasibility parameter: attitude toward psychological online interventions

    Attitudes will be assessed with the Attitude toward Psychological Online Interventions Questionnaire (APOI, German version by Schröder, 2015).

    Time frame: baseline, 6 weeks, 12 weeks

  14. Feasibility parameter: satisfaction with the intervention

    Assessed with the Client Satisfaction Questionnaire (CSQ-8, German version by Schmidt, 1989, and adapted for internet interventions).

    Time frame: 6 weeks, 12 weeks (REMOTION group only)

Other outcomes

  1. Therapeutic alliance

    Alliance will be assessed with the Working Alliance Inventory (WAI-SR, German version by Wilmers et al., 2008)

    Time frame: 6 weeks, twelve weeks

  2. Self Compassion

    Assessed with the Self Compassion Scale (German version by Hupfeld \& Ruffieux, 2011)

    Time frame: baseline, six weeks, twelve weeks

  3. Negative effects of REMOTION

    Assessed with an adapted version of the Inventory to Assess Negative Effects of Psychotherapy (INEP; Ladwig et al., 2014)

    Time frame: six weeks, 12 weeks (REMOTION group only)

  4. Therapist variables

    Assessed with items created for the study (demographics, use of emotion regulation interventions in therapy, use of online interventions in therapy)

    Time frame: baseline, 6 weeks, 12 weeks

  5. Therapist variables specific to REMOTION

    Assessed with items created for the study (for example perceived effect of REMOTION etc.)

    Time frame: 6 weeks, 12 weeks (REMOTION group only)

  6. Patient emotion regulation difficulties as rated by the therapist

    Assessed with the DERS-t (modified version of the German version by Ehring et al., 2008)

    Time frame: baseline, 6 weeks,12 weeks

  7. Patient emotion regulation competencies as rated by the therapist

    Assessed with the SEK-27-t (modified version of the German version by Bering \& Znoj, 2008)

    Time frame: baseline, 6 weeks, 12 weeks

07

Study locations

1 site
  • Psychotherapeutische Praxisstelle, Universität Bern
    Bern, 3012, Switzerland
08

References and documents

Publications

  • Bielinski LL, Krieger T, Moggi F, Trimpop L, Willutzki U, Nissen C, Berger T. REMOTION Blended Transdiagnostic Intervention for Symptom Reduction and Improvement of Emotion Regulation in an Outpatient Psychotherapeutic Setting: Protocol for a Pilot Randomized Controlled Trial. JMIR Res Protoc. 2020 Nov 12;9(11):e20936. doi: 10.2196/20936. PubMed 33180026 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 10, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04262726
Lead sponsor
University of Bern
Responsible party
Sponsor
First posted
Feb 10, 2020
Start date
Feb 26, 2020
Primary completion
Nov 27, 2022
Completion
Nov 27, 2022
Last update
Jan 10, 2023

Study contacts

Thomas Berger, Prof. Dr.
principal investigator · Department of Clinical Psychology and Psychotherapy, Institute of Psychology, University of Bern

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion